Neo Ivy Capital Management Invests $1.55 Million in Privia Health Group, Inc. $PRVA

Neo Ivy Capital Management purchased a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) during the second quarter, HoldingsChannel reports. The firm purchased 67,526 shares of the company’s stock, valued at approximately $1,553,000.

Several other large investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its holdings in Privia Health Group by 6.3% in the 2nd quarter. Geode Capital Management LLC now owns 2,655,569 shares of the company’s stock valued at $61,086,000 after purchasing an additional 158,521 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Privia Health Group by 180.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock valued at $59,112,000 after buying an additional 1,693,870 shares during the period. Van Berkom & Associates Inc. acquired a new stake in shares of Privia Health Group in the 1st quarter valued at approximately $45,207,000. Northern Trust Corp boosted its stake in shares of Privia Health Group by 2.2% in the first quarter. Northern Trust Corp now owns 1,423,865 shares of the company’s stock valued at $31,966,000 after buying an additional 31,224 shares in the last quarter. Finally, Nuveen LLC acquired a new position in Privia Health Group during the first quarter worth $26,899,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Stock Up 0.1%

Privia Health Group stock opened at $22.55 on Friday. The firm has a market capitalization of $2.77 billion, a PE ratio of 173.47, a P/E/G ratio of 3.75 and a beta of 0.83. Privia Health Group, Inc. has a 52 week low of $18.77 and a 52 week high of $26.51. The firm’s 50-day simple moving average is $24.19 and its 200 day simple moving average is $22.78.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The company had revenue of $213.61 million during the quarter. On average, research analysts expect that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have commented on PRVA. Citizens Jmp raised their target price on Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a report on Friday, November 7th. Evercore ISI increased their price target on shares of Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a report on Friday, November 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a report on Wednesday. Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 19th. Finally, Canaccord Genuity Group lifted their price target on shares of Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, November 12th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $30.00.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.